| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | CN1980927A Pyrazolopyridine derivatives |
| 06/13/2007 | CN1980915A Compounds. |
| 06/13/2007 | CN1980914A Novel hydantoin derivatives for the treatment of obstructive airway diseases. |
| 06/13/2007 | CN1980908A Substituted thiazoleacetic as CRTH2 ligands |
| 06/13/2007 | CN1977958A Chinese herbal medicine cold tea |
| 06/13/2007 | CN1977953A Chinese medicine granule for treating children's cold |
| 06/13/2007 | CN1977949A Chinese medicine particle preparation for relieving cough and eliminating phlegm and its preparing method |
| 06/13/2007 | CN1977914A Chinese medicine preparation for treating cough and asthma, and its preparing method and quality coutrol method |
| 06/13/2007 | CN1977912A Chinese medicinal composition for treating cold |
| 06/13/2007 | CN1977911A Honeyed pill medicine for treating chronic laryngopharyngitis and its preparing method |
| 06/13/2007 | CN1977907A Eriobotuya japonica extract, and composition containing same and use |
| 06/13/2007 | CN1977879A Method for preparing bitter gourd cream and bitter gourd cream product |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977832A Novel sterile powder injection containing sodium new houttuyfonate orits receivable salt or derivative |
| 06/13/2007 | CN1321189C Comprehensive utilization process for gingko episperm |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/13/2007 | CN1320909C Rhinitis liquid and its preparing method |
| 06/13/2007 | CN1320901C Medicine for treating lung carbuncle disease |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230078 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229623 Her-2/neu fusion proteins |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/07/2007 | WO2007064272A1 Benzhydryl amide derivatives as cannabinoid receptor antagonists or inverse agonists |
| 06/07/2007 | WO2007063935A1 Aromatic compound |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2007063311A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007063308A2 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007063010A1 Novel vinylogous acids derivatives |
| 06/07/2007 | WO2007062773A1 Oxadiazole derivatives with crth2 receptor activity |
| 06/07/2007 | WO2007062678A1 Phenoxyacetic acid derivatives as crth2 receptor ligands |
| 06/07/2007 | WO2007062677A1 Thiazolyl- and pyrimidinyl-acetic acids and their use as crth2 receptor ligands |
| 06/07/2007 | WO2007041440A3 Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers |
| 06/07/2007 | WO2007031977A3 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 06/07/2007 | US20070129420 New pyrrolidinium derivatives |
| 06/07/2007 | US20070129398 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases |
| 06/07/2007 | US20070129317 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128648 Methods for the Identification of IKKalpha Function and other Genes Useful for Treatment of Inflammatory Diseases |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128192 Human antibody molecules for il-13 |
| 06/07/2007 | CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2631652A1 Oxadiazole derivatives with crth2 receptor activity |
| 06/07/2007 | CA2631232A1 Novel vinylogous acids derivatives |
| 06/07/2007 | CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2629037A1 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 06/06/2007 | EP1793006A2 Nucleic acid ligands and improved methods for producing the same |
| 06/06/2007 | EP1792915A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2007 | EP1792619A1 Beta-sitosterol for treating porcine respiratory disease complex |
| 06/06/2007 | EP1791815A2 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 06/06/2007 | EP1791568A2 Therapeutic uses of inhibitors of rtp801 |
| 06/06/2007 | EP1791555A1 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
| 06/06/2007 | EP1791552A2 Protein a compositions and methods of use |
| 06/06/2007 | EP1791534A1 Pharmaceutical composition comprising an isomer of a betamimetic agent and an anti-cholinergic agent |
| 06/06/2007 | EP1542666B1 Modafinil pharmaceutical compositions |
| 06/06/2007 | EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 06/06/2007 | EP1363874B1 Tryptase inhibitors |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |
| 06/06/2007 | CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines |
| 06/06/2007 | CN1973884A Bobei throat-fitting buccal tablet |
| 06/06/2007 | CN1973871A Largngopharyngitis treating medicine composition and its prepn |
| 06/06/2007 | CN1973866A Quality control method for cold treating and cough relieving syrup |
| 06/06/2007 | CN1973850A Medicine composition for treating allergic rhinitis and its prepn process |
| 06/06/2007 | CN1973827A Prepn process of superfine inhaled glucocorticoid medicine powder |
| 06/06/2007 | CN1319968C Compositions useful as inhibitors of GSK-3 |
| 06/06/2007 | CN1319963C Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/06/2007 | CN1319955C Moguisteine crystallographic form |
| 06/06/2007 | CN1319596C Preparation process of S190 polypeptide vaccine and its application in resisting SARS virus |
| 06/06/2007 | CN1319578C Chinese medicine compound preparation, its preparation method and use |
| 06/06/2007 | CN1319542C Chinese medicine for treating rhinitis |
| 06/06/2007 | CN1319533C Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method |
| 06/06/2007 | CN1319526C Application of soybean isoflavone in the prevention and treatment of anoxic hypertensive pulmonary vascular disease |
| 06/05/2007 | USRE39681 1-(4-sulfamyaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 06/05/2007 | US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders |
| 06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 06/05/2007 | US7226934 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 06/05/2007 | US7226614 segmented; sustained release; for treatment of allergies |
| 06/05/2007 | CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/05/2007 | CA2293836C Polymorphic form of a tachykinin receptor antagonist |
| 06/05/2007 | CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |